Eveline Stock, MD

Associate Professor

Dr. Eveline Oestreicher Stock is a cardiologist specializing in general cardiology and cholesterol metabolism disorders. Her special interests include preventive cardiology, mechanisms of coronary artery disease, heart disease risk assessment, and heart disease women and in the young.

Education
2018 - Diversity, Equity, and Inclusion Champion Training, University of California
Advanced Lipid Disorders, 2013 - Cardiovascular Research Institute, University of California, San Francisco
Fellowship, 2012 - Preventive Cardiology, University of California, San Francisco
Fellowship, 2010 - Cardiology, University of California, San Francisco
Residency, 2007 - Medicine, Harvard School of Medicine - Massachusetts General Hospital
Fellowship, 1999 - Endocrinology, P. Universidad Catolica de Chile
M.D., 1994 - School of Medicine, P. Universidad Catolica de Chile
Publications

  1. Maron DJ, Budoff MJ, Sky JC, Bommer WJ, Epstein SD, Fisher DA, Stock EO, Taylor AJ, Wong ND, DeMaria AN. Coronary Artery Calcium Staging to Guide Preventive Interventions: A Proposal and Call to Action. JACC. Advances 2024. PMID: 39385944


  2. Duncan KO, Stock EO, Damian DL, Miller SJ. Nicotinamide for high-risk skin cancer patients: An update. Journal of the American Academy of Dermatology 2024. PMID: 39297848


  3. Saharan SS, Nagar P, Creasy KT, Stock EO, Feng J, Malloy MJ, Kane JP. Logistic Regression and Statistical Regularization Techniques for Risk Classification of Coronary Artery Disease using Cytokines transported by high density lipoproteins. Proceedings. International Conference on Computational Science and Computational Intelligence 2024. PMID: 39484231


  4. Saharan SS, Nagar P, Creasy KT, Stock EO, Feng J, Malloy MJ, Kane JP. Smoking Classification Using Novel Plasma Cytokines by implementing Machine Learning and Statistical Methods. Proceedings. International Conference on Computational Science and Computational Intelligence 2024. PMID: 39450278


  5. Rakic JM, Pullinger CR, Van Blarigan EL, Movsesyan I, Stock EO, Malloy MJ, Kane JP. APOL1 Risk Variants Associate With the Prevalence of Stroke in African American Current and Past Smokers. Journal of the American Heart Association 2023. PMID: 38084718


  6. Mustra Rakic J, Pullinger CR, Van Blarigan EL, Movsesyan I, Oestreicher Stock E, Malloy MJ, Kane JP. APOL1 Risk Variants Associate with the Prevalence of Stroke in African American Current and Past Smokers. medRxiv : the preprint server for health sciences 2023. PMID: 37162992


  7. Ivey SL, Hanley HR, Taylor C, Stock E, Vora N, Woo J, Johnson S, Bairey Merz CN, Right Care Women's Cardiovascular Writing Group. Early identification and treatment of women's cardiovascular risk factors prevents cardiovascular disease, saves lives, and protects future generations: Policy recommendations and take action plan utilizing policy levers. Clinical cardiology 2022. PMID: 36128629


  8. Mustra Rakic J, Zeng S, Rohdin-Bibby L, Van Blarigan EL, Liu X, Ma S, Kane JP, Redberg RF, Turino GM, Oestreicher Stock E, Arjomandi M. Elastin Degradation and Lung Function Deterioration with Remote Secondhand Tobacco Smoke Exposure in Never-smokers. 2022. PMID: 35700534


  9. Saharan SS, Nagar P, Creasy KT, Stock EO, Feng J, Malloy MJ, Kane JP. Machine learning and statistical approaches for classification of risk of coronary artery disease using plasma cytokines. BioData mining 2021. PMID: 33858484


  10. Wei J, Shufelt C, Oestreicher Stock E, Mills C, Dhawan S, Jacob R, Torbati T, Cook-Wiens G, Benowitz N, Jacob P, Ganz P, Bairey Merz CN, Redberg R. Vascular Aging is Accelerated in Flight Attendants with Occupational Secondhand Smoke Exposure. Journal of occupational and environmental medicine 2018. PMID: 30475308


  11. Stock EO, Ferrara CT, O'Connor PM, Naya-Vigne JM, Frost PH, Malloy MJ, Kane JP, Pullinger CR. Levels of prebeta-1 high-density lipoprotein are elevated in 3 phenotypes of dyslipidemia. Volume 12 of Issue 1. Journal of clinical lipidology 2017. PMID: 29198898


  12. Quinn AG, Schwemberger R, Stock EO, Movsesyan I, Axtell A, Chang S, Ishida BY, Malloy MJ, Kane JP, Pullinger CR. Moderate statin treatment reduces prebeta-1 high-density lipoprotein levels in dyslipidemic patients. Journal of clinical lipidology 2017. PMID: 28558949


  13. Pullinger CR, Stock EO, Movsesyan I, Malloy MJ, Frost PH, Tripuraneni R, Quinn AG, Ishida BY, Schaefer EJ, Asztalos BF, Kane JP. Identification and metabolic profiling of patients with lysosomal acid lipase deficiency. Volume 9 of Issue 5. Journal of clinical lipidology 2015. PMID: 26350820


  14. Mak AC, Pullinger CR, Tang LF, Wong JS, Deo RC, Schwarz JM, Gugliucci A, Movsesyan I, Ishida BY, Chu C, Poon A, Kim P, Stock EO, Schaefer EJ, Asztalos BF, Castellano JM, Wyss-Coray T, Duncan JL, Miller BL, Kane JP, Kwok PY, Malloy MJ. Effects of the absence of apolipoprotein e on lipoproteins, neurocognitive function, and retinal function. Volume 71 of Issue 10. JAMA neurology 2014. PMID: 25111166


  15. Valayannopoulos V, Malinova V, Honzík T, Balwani M, Breen C, Deegan PB, Enns GM, Jones SA, Kane JP, Stock EO, Tripuraneni R, Eckert S, Schneider E, Hamilton G, Middleton MS, Sirlin C, Kessler B, Bourdon C, Boyadjiev SA, Sharma R, Twelves C, Whitley CB, Quinn AG. Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiency. Journal of hepatology 2014. PMID: 24993530


  16. Nosova EV, Yen P, Chong KC, Alley HF, Stock EO, Quinn A, Hellmann J, Conte MS, Owens CD, Spite M, Grenon SM. Short-term physical inactivity impairs vascular function. The Journal of surgical research 2014. PMID: 24630521


  17. Balwani M, Breen C, Enns GM, Deegan PB, Honzík T, Jones S, Kane JP, Malinova V, Sharma R, Stock EO, Valayannopoulos V, Wraith JE, Burg J, Eckert S, Schneider E, Quinn AG. Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease. Hepatology (Baltimore, Md.) 2013. PMID: 23348766


  18. Stock EO, Redberg R. Cardiovascular disease in women. Volume 37 of Issue 11. Current problems in cardiology 2012. PMID: 23047015


  19. Ricchiuti V, Lian CG, Oestreicher EM, Tran L, Stone JR, Yao T, Seely EW, Williams GH, Adler GK. Estradiol increases angiotensin II type 1 receptor in hearts of ovariectomized rats. The Journal of endocrinology 2008. PMID: 18931023


  20. O'Donoghue M, Kenney P, Oestreicher E, Anwaruddin S, Baggish AL, Krauser DG, Chen A, Tung R, Cameron R, Januzzi JL. Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study). The American journal of cardiology 2007. PMID: 17950786


  21. Sakhuja R, Green S, Oestreicher EM, Sluss PM, Lee-Lewandrowski E, Lewandrowski KB, Januzzi JL. Amino-terminal pro-brain natriuretic peptide, brain natriuretic peptide, and troponin T for prediction of mortality in acute heart failure. Clinical chemistry 2007. PMID: 17259237


  22. Guo C, Martinez-Vasquez D, Mendez GP, Toniolo MF, Yao TM, Oestreicher EM, Kikuchi T, Lapointe N, Pojoga L, Williams GH, Ricchiuti V, Adler GK. Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus. Endocrinology 2006. PMID: 16901964


  23. López JM, Oestreicher E. Reversal of hypogonadotropic hypogonadism with tamoxifen in a patient with hyperprolactinemia resistant to dopamine agonists. Fertility and sterility 2005. PMID: 16169415


  24. Villaseca P, Campino C, Oestreicher E, Mayerson D, Serón-Ferré M, Arteaga E. Bilateral oophorectomy in a pregnant woman: hormonal profile from late gestation to post-partum: case report. Human reproduction (Oxford, England) 2004. PMID: 15528265


  25. Carrasco CA, González AA, Carvajal CA, Campusano C, Oestreicher E, Arteaga E, Wohllk N, Fardella CE. Novel intronic mutation of MEN1 gene causing familial isolated primary hyperparathyroidism. The Journal of clinical endocrinology and metabolism 2004. PMID: 15292357


  26. Oestreicher EM, Martinez-Vasquez D, Stone JR, Jonasson L, Roubsanthisuk W, Mukasa K, Adler GK. Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury. Circulation 2003. PMID: 14581407


  27. Martinez DV, Rocha R, Matsumura M, Oestreicher E, Ochoa-Maya M, Roubsanthisuk W, Williams GH, Adler GK. Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading. Hypertension (Dallas, Tex. : 1979) 2002. PMID: 11882618